Market Caution – US Biotech Stocks Look OverHeated

ARE BIOTECH STOCKS IN A BUBBLE?

ARE BIOTECH STOCKS IN A BUBBLE?

This is a question that is being asked. According to an article by Bloomberg (Biotech Index in Nosebleed Territory – Up 500% In 4-years, Trades At 10X Revenues – Bloomberg Business, March 8, 2015) the 269 Biotech companies that are listed on the NASDAQ are up more than 500% in the past four years. The Biotech companies have the biggest weighting on the NASDAQ at 11.2%.
A 500% gain is impressive. The NASDAQ Biotechnology Index (NBI) is up a more modest 338%. The TSX Health Care Index (THC) is up an even more modest 187% in the same period. It appears that some of the really high flyers are not even in the NBI. As to the THC, it has been led primarily by one stock – Valeant Pharmaceutical (VRX-TSX). VRX is up 665% in the same period.Read More.

Be Extra Cautious As Rumors Began Last Year

Excerpt from:  

Market Caution – US Biotech Stocks Look OverHeated

See which stocks are being affected by Social Media